GB1463520A
(en)
*
|
1974-09-06 |
1977-02-02 |
Pfizer Ltd |
Process for the production of imidazolines
|
JPS5373571A
(en)
*
|
1976-12-10 |
1978-06-30 |
Otsuka Pharmaceut Co Ltd |
Carbostyril derivatives
|
JPS542338A
(en)
|
1977-04-22 |
1979-01-09 |
Sandoz Ag |
Pharmaceutical composition
|
US4188393A
(en)
|
1977-04-22 |
1980-02-12 |
Sandoz Ltd. |
Treating spastic conditions or relaxing muscles
|
FR2449087A2
(fr)
*
|
1979-02-16 |
1980-09-12 |
Rhone Poulenc Ind |
Nouveaux derives de l'isoquinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent
|
US4486432A
(en)
*
|
1982-09-30 |
1984-12-04 |
Eli Lilly And Company |
Quinoxalinedione leukotriene release inhibitors
|
FR2541680B1
(fr)
*
|
1983-02-24 |
1985-06-14 |
Rhone Poulenc Sante |
Nouveaux derives de l'amino-5 dithiole-1,2 one-3, leur preparation et les compositions medicinales qui les contiennent
|
JPS6118950U
(ja)
*
|
1984-07-10 |
1986-02-03 |
財団法人鉄道総合技術研究所 |
トロリ線の給油装置
|
JPS63296814A
(ja)
*
|
1987-05-29 |
1988-12-02 |
Ishigaki Kiko Kk |
集塵装置における濾材の目詰り除去装置
|
GB8827820D0
(en)
*
|
1988-11-29 |
1988-12-29 |
Janssen Pharmaceutica Nv |
(1h-azol-1-ylmethyl)substituted quinoline derivatives
|
US5281591A
(en)
*
|
1989-05-22 |
1994-01-25 |
Allergan, Inc. |
Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
|
US5180721A
(en)
*
|
1989-05-22 |
1993-01-19 |
Allergan, Inc. |
Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
|
US5326763A
(en)
*
|
1989-10-12 |
1994-07-05 |
Allergan, Inc. |
Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
|
US5231096A
(en)
*
|
1989-10-12 |
1993-07-27 |
Allergan, Inc. |
Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
|
US5112822A
(en)
*
|
1989-10-12 |
1992-05-12 |
Allergan, Inc. |
(2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
|
US5077292A
(en)
*
|
1989-10-12 |
1991-12-31 |
Allergan, Inc. |
(2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
|
US5204347A
(en)
*
|
1989-10-12 |
1993-04-20 |
Allergan, Inc. |
Methods for using (2-imidazolin-2-ylamino) tetrahydroquinoxalines
|
US5198442A
(en)
*
|
1989-10-12 |
1993-03-30 |
Allergan, Inc. |
(2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
|
US5021416A
(en)
*
|
1989-10-31 |
1991-06-04 |
Allergan, Inc. |
Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
|
US5215991A
(en)
*
|
1990-01-26 |
1993-06-01 |
Allergan, Inc. |
Combination of selective alpha-adrenergic agonists and Na+ /H+ ex
|
US5237072A
(en)
*
|
1990-02-06 |
1993-08-17 |
Allergan, Inc. |
Method for producing amino-2-imidazoline derivatives
|
US5130441A
(en)
*
|
1990-02-06 |
1992-07-14 |
Allergan, Inc. |
Method for producing amino-2-imidazoline derivatives
|
US5252595A
(en)
*
|
1990-02-28 |
1993-10-12 |
Allergan, Inc. |
Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenylamino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines
|
US5091528A
(en)
*
|
1990-09-12 |
1992-02-25 |
Allergan, Inc. |
6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
|
JP3683908B2
(ja)
*
|
1993-10-13 |
2005-08-17 |
アラーガン、インコーポレイテッド |
(2−イミダゾリン−2−イルアミノ)キノキサリン誘導体の使用方法
|
US6323204B1
(en)
*
|
1993-10-13 |
2001-11-27 |
Allergan |
Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
|
US5580892A
(en)
*
|
1993-10-22 |
1996-12-03 |
Allergan |
Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents
|
US5478858A
(en)
*
|
1993-12-17 |
1995-12-26 |
The Procter & Gamble Company |
5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
|
US5578607A
(en)
*
|
1993-12-17 |
1996-11-26 |
The Procter & Gamble Company |
6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
|
DE69425334T2
(de)
*
|
1993-12-17 |
2001-02-08 |
Procter & Gamble |
6-(2-imidazolinylamino) chinoxalin-verbindungen als alpha-2-adrenorezeptoragonisten
|
US5576437A
(en)
*
|
1993-12-17 |
1996-11-19 |
The Procter & Gamble Company |
7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
|
ATE192150T1
(de)
*
|
1993-12-17 |
2000-05-15 |
Procter & Gamble |
6-(2-imidazolinylamino)chinolin-verbindungen als alpha-2-adrenoceptor-antagonisten
|
ATE153330T1
(de)
*
|
1994-02-08 |
1997-06-15 |
Alcon Lab Inc |
Neues verfahren zur herstellung von clonidin- derivaten
|
AU704972B2
(en)
|
1994-08-04 |
1999-05-13 |
H. Lundbeck A/S |
Novel benzimidazole derivatives
|
US6294563B1
(en)
|
1994-10-27 |
2001-09-25 |
Allergan Sales, Inc. |
Combinations of prostaglandins and brimonidine or derivatives thereof
|
US6194415B1
(en)
*
|
1995-06-28 |
2001-02-27 |
Allergan Sales, Inc. |
Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury
|
US5916900A
(en)
*
|
1995-06-29 |
1999-06-29 |
The Procter & Gamble Company |
7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
|
JP2001506600A
(ja)
|
1996-11-25 |
2001-05-22 |
ザ プロクター アンド ギャンブル カンパニー |
α―2アドレナリン受容体作動薬として有用なグアニジニル複素環式化合物
|
AU736992B2
(en)
*
|
1996-11-25 |
2001-08-09 |
Procter & Gamble Company, The |
2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
|
WO1998023612A1
(en)
*
|
1996-11-25 |
1998-06-04 |
The Procter & Gamble Company |
2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists
|
US6306877B1
(en)
|
1999-08-09 |
2001-10-23 |
The Procter & Gamble Co. |
Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
|
US6172095B1
(en)
|
1996-11-25 |
2001-01-09 |
The Procter & Gamble Company |
Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
|
SK68399A3
(en)
*
|
1996-11-25 |
2000-07-11 |
Procter & Gamble |
2-imidazolinylaminoindole compound, pharmaceutical composition containing the same and use thereof
|
US6495583B1
(en)
|
1997-03-25 |
2002-12-17 |
Synaptic Pharmaceutical Corporation |
Benzimidazole derivatives
|
KR20010032435A
(ko)
|
1997-11-24 |
2001-04-25 |
데이비드 엠 모이어 |
5-(2-이미다졸리닐아미노)벤즈이미다졸 유도체, 그의 제조및 대사 안정성이 개선된 알파-아드레날린수용체아고니스트로서의 그의 용도
|
WO2004073708A1
(en)
|
1998-12-17 |
2004-09-02 |
Dean Thomas R |
Brinzolamide and brimonidine for treating ocular conditions
|
JP2004503593A
(ja)
|
2000-07-14 |
2004-02-05 |
アラーガン、インコーポレイテッド |
増大した溶解度を持つ治療活性成分を含む組成物
|
US20050026924A1
(en)
*
|
2000-07-14 |
2005-02-03 |
Allergan, Inc. |
Compositions containing alpha-2-adrenergic agonist components
|
EP1365811A2
(de)
*
|
2000-07-14 |
2003-12-03 |
Allergan, Inc. |
Zusammensetzungen enthaltend alpha-2-adrenergische agonisten
|
US8858961B2
(en)
|
2000-07-14 |
2014-10-14 |
Allergan, Inc. |
Compositions containing alpha-2-adrenergic agonist components
|
US20040214829A1
(en)
*
|
2000-07-14 |
2004-10-28 |
Allergan, Inc. |
Compositions containing alpha-2-adrenergic agonist components
|
DE10161767A1
(de)
*
|
2001-12-15 |
2003-06-26 |
Merck Patent Gmbh |
2-Guanidino-4-heterocyclyl-chinazoline
|
US7642258B2
(en)
*
|
2002-04-19 |
2010-01-05 |
Allergan, Inc. |
Combination of brimonidine and timolol for topical ophthalmic use
|
US7030149B2
(en)
|
2002-04-19 |
2006-04-18 |
Allergan, Inc. |
Combination of brimonidine timolol for topical ophthalmic use
|
EP1549305B1
(de)
*
|
2002-10-08 |
2009-04-22 |
Allergan, Inc. |
Alpha 2b oder 2b/2c adrenozeptor-agonisten zur behandlung von morbus alzheimer und morbus parkinson
|
CN100370988C
(zh)
*
|
2002-10-08 |
2008-02-27 |
阿勒根公司 |
(2-咪唑啉-2-基氨基)喹噁啉在制备治疗痴呆症和帕金森病的药物中的用途
|
US20040191332A1
(en)
*
|
2003-03-27 |
2004-09-30 |
Allergan, Inc. |
Preserved ophthalmic compositions
|
US7439241B2
(en)
|
2003-05-27 |
2008-10-21 |
Galderma Laboratories, Inc. |
Compounds, formulations, and methods for treating or preventing rosacea
|
US8410102B2
(en)
|
2003-05-27 |
2013-04-02 |
Galderma Laboratories Inc. |
Methods and compositions for treating or preventing erythema
|
WO2005014046A2
(en)
*
|
2003-08-07 |
2005-02-17 |
Allergan, Inc. |
Compositions for delivery of therapeutics into the eyes and methods for making and using the same
|
US7501427B2
(en)
|
2003-08-14 |
2009-03-10 |
Array Biopharma, Inc. |
Quinazoline analogs as receptor tyrosine kinase inhibitors
|
CN102432552B
(zh)
*
|
2003-08-14 |
2016-01-20 |
阿雷生物药品公司 |
作为受体酪氨酸激酶抑制剂的喹唑啉类似物
|
US20070042951A1
(en)
*
|
2003-10-08 |
2007-02-22 |
Allergan, Inc. |
Pharmaceutical compositions comprising alpha-2-adrenergics and trefoil factor family peptides
|
BRPI0511519A
(pt)
|
2004-05-25 |
2007-12-26 |
Sansrosa Pharmaceutical Dev In |
método para tratar ou prevenir um distúrbio inflamatório da pele e os sintomas associados com ele, composição tópica adequada para tratar ou evitar os sintomas de um distúrbio inflamatório dermatológico, e, embalagem para uma composição tópica
|
US7534795B2
(en)
*
|
2005-10-25 |
2009-05-19 |
Allergan, Inc. |
Compounds and their use related to compositions for treating disease
|
JP2009514969A
(ja)
|
2005-11-09 |
2009-04-09 |
コンビナトアールエックス インコーポレーティッド |
医学的状態を治療するための方法、組成物、およびキット
|
CA2755268C
(en)
*
|
2005-11-15 |
2013-12-31 |
Array Biopharma, Inc. |
Erbb inhibitors
|
WO2008074068A1
(en)
*
|
2006-12-20 |
2008-06-26 |
Prana Biotechnology Limited |
Substituted quinoline derivatives as antiamyloidogeneic agents
|
WO2008144399A1
(en)
*
|
2007-05-18 |
2008-11-27 |
Bausch & Lomb Incorporated |
COMPLEXES COMPRISING α2-ADRENERGIC RECEPTOR AGONISTS AND COMPOSITIONS
|
US7842714B2
(en)
*
|
2008-03-03 |
2010-11-30 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating ocular pain
|
US9192571B2
(en)
*
|
2008-03-03 |
2015-11-24 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating or preventing ocular pain
|
EP3584237B1
(de)
|
2009-10-06 |
2020-12-09 |
Allergan, Inc. |
Alpha-adrenergische rezeptormodulatoren
|
EP2329849B1
(de)
|
2009-11-18 |
2015-04-29 |
Galderma Research & Development |
Kombination aus einem Alpha-2-Adrenozeptor-Agonisten und einem nichtsteroidalen entzündungshemmenden Mittel zur Behandlung oder Prävention einer Entzündungskrankheit der Haut
|
US8394800B2
(en)
|
2009-11-19 |
2013-03-12 |
Galderma Laboratories, L.P. |
Method for treating psoriasis
|
US9522153B2
(en)
|
2009-12-22 |
2016-12-20 |
Allergan, Inc. |
Compositions and methods for lowering intraocular pressure
|
MX2012010824A
(es)
|
2010-03-26 |
2012-10-10 |
Galderma Res & Dev |
Metodos y composiciones mejoradas para tratamiento seguro y efectivo del eritema.
|
AU2011231544B2
(en)
|
2010-03-26 |
2015-01-15 |
Galderma Research & Development |
Improved methods and compositions for safe and effective treatment of telangiectasia
|
CA2796041A1
(en)
|
2010-04-07 |
2011-10-13 |
Allergan, Inc. |
Combinations of preservative compositions for ophthalmic formulations
|
EP2555748A2
(de)
|
2010-04-07 |
2013-02-13 |
Allergan, Inc. |
Konservierungsstoffkombinationen für ophthalmische zusammensetzungen
|
PT2598119T
(pt)
|
2010-07-29 |
2018-12-17 |
Allergan Inc |
Soluções de brimonidina e timolol isentas de conservantes
|
US8053427B1
(en)
|
2010-10-21 |
2011-11-08 |
Galderma R&D SNC |
Brimonidine gel composition
|
WO2012052479A2
(en)
|
2010-10-21 |
2012-04-26 |
Galderma S.A. |
Brimonidine gel compositions and methods of use
|
KR20140062471A
(ko)
|
2011-07-25 |
2014-05-23 |
알러간, 인코포레이티드 |
알파 2 아드레날린 수용체의 조절물질로서의 n-(이미다졸리딘-2-일리덴)퀴놀린 유도체
|
GR1009419B
(el)
|
2017-11-07 |
2018-12-14 |
Φαρματεν Αβεε |
Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου
|